Aetna Becomes First National Payor to Cover Incisionless Treatment for Tremor Dominant Parkinson’s Disease

Positive coverage decision expands access to focused ultrasound for more than 1 million Americans living with Parkinson’s Disease.

HAIFA, Israel and MIAMI, FL (April 17, 2025) – Insightec, a global healthcare innovator dedicated to using focused ultrasound to transform patient care, today announced that Aetna is now the first national payor to offer commercial coverage of therapeutic ultrasound treatment for tremor-dominant Parkinson’s Disease (PD). In addition, Anthem provides coverage for unilateral pallidotomy for the motor complications of PD. These milestone decisions expand access to the incisionless treatment alternative for people when their medications have been unsuccessful.

Focused ultrasound, pioneered by Insightec, has emerged as an incisionless outpatient treatment option for patients with tremors that remain disabling even with optimized medications. With this latest decision, an additional 39 million lives are now covered for tremor-dominant PD, bringing the total number of insured lives with access to the procedure to 59 million—including those covered through local Medicare Administrative Contractors. For unilateral pallidotomy for the motor complications of PD, Anthem covers 34.5 million lives.

“This is a meaningful milestone towards our mission to improve the quality of life and care for people living with Parkinson’s Disease” said Maurice R. Ferré, M.D., Insightec CEO and Chairman. “With Parkinson’s expected to affect 1.2 million Americans by 2030—and as our population continues to age—ensuring equitable access to effective, incisionless treatment is more important than ever. These decisions not only expand access today, but they also help lay the groundwork for us in the future.”

There are currently 83 treatment centers in the U.S. and 192 treatment centers around the world using Insightec’s Exablate® Neuro platform. Over 22,000 patients have been treated globally with the platform for movement disorders, including Essential Tremor and PD.

About Insightec

Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company’s Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide treatment to patients with medication-refractory essential tremor and Parkinson’s disease*. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. Insightec is headquartered in Haifa, Israel, and Miami, with offices in Dallas, Shanghai, and Tokyo.

*For detailed country specific indications visit https://insightec.com/regulatory-approvals/

Follow us on Facebook, LinkedIn and Twitter or visit www.insightec.com for more information. 

Forward-looking Statements:

This document contains forward-looking statements regarding, among other things, plans, expectations, and future events. In some cases, forward-looking statements can be identified by the following words: “may,” “can,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “promise,” “continue,” “ongoing,” or the negative of these terms. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Insightec as of the date of the statement. All written or oral forward-looking statements attributable to Insightec are qualified by this caution. Insightec does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Insightec’s expectations.

“Exablate,” and “Exablate Neuro,” as well as the “INSIGHTEC” logo, whether standing alone or in connection with the word “Insightec,” are protected trademarks of Insightec.

Insightec Media Contact:
G&S Business Communications for Insightec
Marjani Williams
mwilliams@gscommunications.com
(312) 648-6700, ext.2108